Sex hormone binding globulin (SHBG) is a hepatokine that binds to circulating steroid
hormones (testosterone, oestradiol) to regulate their concentration in the bloodstream …

Evidence is accumulating that specifically fructose exerts adverse cardiometabolic effects in
humans. Recent experimental studies have shown that fructose not only serves as a …

Aims/hypothesis Serum sex hormone-binding globulin (SHBG) has been proposed to act as
a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic …

Equine metabolic syndrome (EMS) is a steadily growing endocrine disorder representing a
real challenge in veterinary practice. As a multifactorial condition, EMS is characterized by …

In a 3-arm presurgical trial, four-six weeks exemestane 25 mg three times/week (TIW) was
non-inferior to 25 mg/day (QD) in suppressing circulating estradiol in postmenopausal …

The aim of this study was to investigate the associations among sex hormone–binding
globulin (SHBG), visceral adipose tissue (VAT), liver fat content, and risk of type 2 diabetes …

Objective A recent Mendelian randomization study has suggested a causal role for sex
hormone‐binding globulin (SHBG), total testosterone and free testosterone in the …

Polycystic ovary syndrome (PCOS) represents an endocrine condition affecting 5–18% of
adolescents, frequently in association with obesity, metabolic alterations, and liver …

Background and aims Coronary artery disease (CAD) is the principal cause of death in
individuals with non-alcoholic fatty liver disease (NAFLD). The aim of this study was to use …

Peroxisome proliferator-activated receptor gamma (PPARγ) is a transcription factor that
promotes adipogenesis, lipid uptake and storage, insulin sensitivity, and glucose …